Indian pharmaceutical companies started exporting generic drugs to developing countries that were grappling with the high cost of healthcare. The country earned the title of the “pharmacy of the developing world”, providing essential medicines at low prices to countries in Africa, Asia, and Latin America. Yet, the country’s marginalised populations have limited access to medicines as branded medicines are sold at significantly higher prices than their unbranded generic equivalents, despite being identical in the therapeutic value. Therefore, there is an urgent need to ensure the availability of cheaper generics to citizens; this is in the best interest of these populations.
- In developing countries, India is rendering yeoman service by providing access to life saving medicines at affordable prices, he added.
- Generic medicines in India must adhere to the same regulatory standards as branded drugs.
- Under the Scheme, dedicated outlets known as Pradhan Mantri Bhartiya Janaushadhi Kendras (PMBJKs) are opened to provide generic medicines at cheaper rates to the citizens.
- The PMBJP scheme aims to make quality generic medicines available and affordable to all sections of society, especially the economically weaker sections.
- Healthcare and its allied industries being the fifth-largest employer among all sectors, the Vice President asked the industry to invest in skilling.
- We help you to access high quality generic medicine and overcome financial barriers.
- Generic medicines play a crucial role in promoting health equity by ensuring that medications are accessible to all segments of the population, regardless of socioeconomic status.
Benefits of generic drugs
The history of generic medicines in India reflects the country’s commitment to ensuring affordable and accessible healthcare. From legislative changes in the 1970s to the expansion of the global generics market, India’s pharmaceutical industry has grown into a powerhouse. Today, India stands as a leader in the global generic drug market, providing life-saving medicines to millions of people worldwide, while continuing to be a vital player in making healthcare affordable for all. In recent years, generic medicines in India have emerged as a powerful tool in making healthcare more affordable and accessible to millions of people.
Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP)
The paper concludes that the scheme holds immense promise but requires targeted efforts to overcome barriers to acceptance of generic drugs available under the scheme. Recommendations in-clude awareness campaigns, supply-side regulations, pricing policy review, and customer-centric strategies to further enhance the program’s impact and healthcare accessibility in India. The research findings suggest several lapatinib cost uk key recommendations to enhance the Pradhan Mantri Jan Aushadhi Yojana (PMJAY) and improve accessibility, affordability, availabil-ity, and customer satisfaction of generic medicines. Firstly, launching targeted awareness campaigns is crucial to educate the public and healthcare providers about the benefits and quality of generic medicines, addressing misconceptions, and promoting their acceptance.
We Have 5+ Year’s Experience in exporting medicine globally
The primary objective of the study is to assess the Effective-ness, Accessibility, Affordability, Availability, and Customer Satisfaction of generic medicines in the Pradhan Mantri Jan Aushadhi Yojana. Generic medicines play a crucial role in making healthcare more affordable and accessible. They help reduce overall healthcare costs, promote health equity, and support government initiatives like the Pradhan Mantri Jan Aushadhi Yojana (PMJAY). Generic medicines are produced after the patent on a branded drug expires, allowing multiple manufacturers to make the same drug. This competition, along with the lack of R&D and marketing costs, significantly reduces the price of generic medicines.
Are generic medicines as effective as brand-name ones?
They must be approved by regulatory authorities like the Central Drugs Standard Control Organization (CDSCO) in India. Generic medicines are drugs that contain the same active ingredients as branded medicines, but are sold under their chemical name. They are equivalent in dosage, safety, strength, quality, and intended use, offering the same therapeutic benefits at a much lower cost.
How do generic medicines support government healthcare initiatives in India?
There is immense scope for technology, innovation and research in pharmaceuticals. India also has a large pool of talented scientists and engineers who have the potential to lead the industry ahead to greater heights. Generic drugs export has been growing at a very impressive rate of around 24% per year for the last four years.
Newly Launched Generic Medicine
Many rural pharmacies may not stock a wide range of generics due to logistical challenges or low demand, leading patients to rely on more expensive branded alternatives. Generic medicines are drugs that contain the same active ingredients as their brand-name counterparts but are sold under their chemical names, without any brand identity. The only significant difference is the price, as generic drugs are often 30% to 90% cheaper than branded medicines. “Making quality medicines available at affordable prices has been a key challenge. We will reinvigorate the supply of generic drugs. 3,000 Stores under Prime Minister’s Jan Aushadhi Yojana will be opened during 2017.”
Are generic medicines safe and effective?
ConclusionIn conclusion, the PMBJP scheme has been instrumental in making quality generic medicines available and affordable to all sections of society, especially the economically weaker sections in India. The scheme has been successful in increasing the accessibility of medicines to the masses and has helped in reducing healthcare costs for individuals and the government. However, there are still challenges that need to be addressed, such as ensuring the availability and accessibility of medicines in remote areas. The potential of the PMBJP to expand and cover more medicines and medical devices is promising, and it can play a crucial role in achieving the goal of universal health coverage in India.
How do generic medicines support government healthcare initiatives in India?
The product basket presently comprises of 1,451 medicines and 240 surgical items covering all major therapeutic groups such as Cardiovascular, Anti-cancers, Anti-diabetics, Anti-infectives, Anti-allergic, Gastro-intestinal medicines, Nutraceuticals, etc. These medicines are available through more than 8,600 PMBJKs functioning across the country. In December 2023, the Department of Pharmaceuticals announced the availability of Jan Aushadhi Suvidha Oxo-Biodegradable Sanitary Napkins at Rs. 1 to ensure easy accessibility of and provide affordable sanitary napkins to women in India. From the beginning until November 30, 2023, more than 47.87 crore Jan Aushadhi Suvidha Sanitary Pads have been purchased from Jan Aushadhi Kendras. The scheme is being implemented by the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (BPPI), under the administrative control of the Department of Pharmaceuticals and the Ministry of Chemicals and Fertilisers. As of FY23, it covers 1,759 medicines and 280 surgical & consumables in all key therapeutic categories such as anti-infective, anti-allergic, anti-diabetics, cardiovascular, anti-cancers, and gastrointestinal medicines.
History of Generic Medicines in India
- This public health approach to setting strict patent standards is in line with international trade rules and encourages timely entry of affordable generics into the market, driving prices down.
- Firstly, launching targeted awareness campaigns is crucial to educate the public and healthcare providers about the benefits and quality of generic medicines, addressing misconceptions, and promoting their acceptance.
- In recent years, generic medicines in India have emerged as a powerful tool in making healthcare more affordable and accessible to millions of people.
- The Vice President said that apart from being the world leader in generic medicines, India should promote Indian systems of Medicine.
- Under this scheme, Jan Aushadhi stores have been set up across India, where generic medicines are sold at affordable prices, making essential drugs accessible even in remote areas.
The Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) Scheme has introduced 2,047 medicines and 300 surgical devices, including cardiovascular, anti-cancer, and anti-diabetic treatments. The initiative aims to make essential medicines more accessible and affordable through resolute PMBJK outlets. While the Pradhan Mantri Jan Aushadhi Yojana (PMJAY) has promoted the use of generic medicines, there is still a lack of awareness about the benefits of generics among the general public and even some healthcare professionals. Many patients are unaware that generic medicines contain the same active ingredients as branded drugs and are equally effective. Generic medicines in India must adhere to the same regulatory standards as branded drugs. The Central Drugs Standard Control Organization (CDSCO) oversees the approval and regulation of generic medicines to ensure they meet high standards of safety, efficacy, and quality.
Efficacy refers to the ability of medicines to produce desired therapeutic effects under ideal conditions. Availability involves the presence of essen-tial medicines in appropriate forms and quantities at healthcare facilities. Customer satisfaction assessed whether expectations regarding quality and experience were met.
- The recombinant Hepatitis B vaccine is an excellent example of one of India’s low-cost medicines.
- With an objective of making quality generic medicines available at affordable prices to all, Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) was launched by the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers in the year 2008.
- Recommendations in-clude awareness campaigns, supply-side regulations, pricing policy review, and customer-centric strategies to further enhance the program’s impact and healthcare accessibility in India.
- With years of experience and partnerships across the pharmaceutical industry, we guarantee timely and secure delivery.
- This leads to lower costs because generic manufacturers do not incur the high expenses of research and marketing.
- The National Institute of Pharmaceutical Education and Research (NIPER) imparts quality education in the areas of pharmaceutical sciences.
- The objective of the research is to assess the effectiveness, accessibility, affordability, availabil-ity, and customer satisfaction of generic medicines available under the Pradhan Mantri Jan Aushadhi Yojana (PMJAY).
He asked for a constant coordination between government and Industry to remove disconnect between demand and supply of skilled manpower in pharmacy sector. In order to ensure quality of the products, PMBI procures medicines only from World Health Organization – Good Manufacturing Practices (WHO-GMP) certified suppliers. Apart from this, each batch of drug is tested at laboratories accredited by ‘National Accreditation Board for Testing and Calibration Laboratories (NABL). Only after passing the quality tests, the medicines are dispatched to PMBJP Kendras. The government has also launched a mobile application ‘Janaushadhi Sugam’ that provides information to public about location of kendras, help them search Janaushadhi medicines and compare the maximum retail price of Generic vs. Branded medicines, etc.
- Similar instructions also have been issued to ‘prescribe drugs with generic name legibly’ to all CGHS Doctors and Wellness Centres.
- Additionally, the erstwhile Medical Council of India (MCI) had issued Circulars vide which all the Registered Medical Practitioners have been directed to comply with the aforesaid provisions.
- This initiative aimed to promote the use of affordable generic medicines by establishing Jan Aushadhi Kendras (stores) across India, where patients could purchase high-quality generic medicines at significantly lower prices than branded drugs.
- They have a common notion that generic drugs are available at a low price so they may be of inferior quality.
- The Indian pharmaceutical industry was relatively underdeveloped, and most medicines, especially life-saving ones, were imported, making them inaccessible to a large part of the population due to high costs.
- Recently, these initiatives have already been started by a few state governments in India.
- The scheme is being implemented by the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (BPPI), under the administrative control of the Department of Pharmaceuticals and the Ministry of Chemicals and Fertilisers.
- This is an eloquent testimony to the competence of the Indian pharma sector in terms of quality and pricing.
- Along with no compromise on quality, it is also cost-effective, as the cost of research and development and drug discovery is not included in the case of generic drugs.
- The government should implement policies that incentivize doctors to prescribe generic medicines.
- Pharmaceuticals is one of the fastest growing contributors to “Make in India” campaign since its inception.
- These issues stem from quality control, regulatory oversight, and consumer perception, all of which can hinder the widespread acceptance and effectiveness of generics in the country.
We deliver medications worldwide, ensuring that patients from all corners of the globe receive the care they need. You can trust Indiangenericprice for reliable access to specialized medications that are affordable and delivered worldwide. Dr. Yussef Hamied from India electrified the world by announcing that the generic company Cipla would manufacture and supply the triple fixed-dose combination of HIV antiretrovirals at $1 a day, a 99.99 percent price cut. Generic drugs are easily available across India, especially with the increasing number of Jan Aushadhi stores in rural and urban areas. New molecules and new drugs will have to be discovered and treatment protocols will have to be continuously upgraded and updated. The National Institute of Pharmaceutical Education and Research (NIPER) imparts quality education in the areas of pharmaceutical sciences.
As previously mentioned, generic medicines are far cheaper than branded drugs, allowing patients to afford treatments for chronic conditions like diabetes, hypertension, and cardiovascular diseases without financial strain. Unlike branded medicines, which spend significantly on advertising and promotion, generic drugs rely less on branding and more on their efficacy, resulting in reduced costs. Indiangenericprice ensures that all our medications are obtained from certified manufacturers, meeting strict global safety and efficacy guidelines.
How do generic medicines support government healthcare initiatives in India?
National Skill Development Coorporation has identified more than 60 job roles for the pharmacy graduates and post gradutes for consideration under the Pradhan Mantri Kaushal Vikas Yojna. Healthcare is the fifth-largest employer among all sectors, both in terms of direct and indirect employment. Given the significance of highly educated and specialized scientists in the sector, skill development is crucial. The government and the Pharma sector in unison have managed to effectively harness the power of Information technology to improve efficiency. Under the National Pharmaceutical Pricing Policy, as on December 15, 2016, ceiling price of 853 formulations are under price control.
These issues stem from quality control, regulatory oversight, and consumer perception, all of which can hinder the widespread acceptance and effectiveness of generics in the country. The Vice President asked Pharma companies to go above and beyond their CSR mandates to provide life saving and other essential drugs to those who cannot afford them. He said that it was essential for a country like India to provide healthcare and medicines at affordable prices. In developing countries, India is rendering yeoman service by providing access to life saving medicines at affordable prices, he added. Medicines in almost every therapeutic category are sold primarily as branded drugs, at disproportionately high prices. There is still a large section of the population which finds it difficult to afford these high-priced medicines.
When looking for effective and affordable treatment choices, Dr. Best advises patients and healthcare professionals to explore generic options. In India, generic medicine sales appear to be on the rise, as long as the government continues to encourage them. Most people worry about the quality and effectiveness of generic medicines because generic drugs are not as costly as compared to branded drugs.
This research explores the Pradhan Mantri Jan Aushadhi Yojana (PMJAY) and its impact on im-proving healthcare drug accessibility, affordability, efficacy, and customer satisfaction through the provision of generic medicines in India. The literature review examines consumer perceptions, knowledge, and attitudes toward generic drugs, highlighting the potential of such initia-tives while acknowledging existing challenges. The objective of the research is to assess the effectiveness, accessibility, affordability, availabil-ity, and customer satisfaction of generic medicines available under the Pradhan Mantri Jan Aushadhi Yojana (PMJAY). Also, a visit to a Pradhan Mantri Jan Aushadhi Kendra was done to evaluate the operational of the scheme. Findings reveal the Pradhan Mantri Jan Aushadhi Yojana (PMJAY) success in providing affordable medicines to underserved populations, generating cost savings, garnering positive feedback from customers, and making them available easily. However, it has been observed that low awareness and misconceptions remain significant hurdles.